GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Solventum Corp (NYSE:SOLV) » Definitions » Research & Development

Solventum (Solventum) Research & Development : $759 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solventum Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Solventum's Research & Development for the three months ended in Mar. 2024 was $195 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $759 Mil.


Solventum Research & Development Historical Data

The historical data trend for Solventum's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Research & Development Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
719.00 766.00 767.00 759.00

Solventum Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 195.00 195.00 179.00 190.00 195.00

Solventum Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $759 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solventum  (NYSE:SOLV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Solventum Research & Development Related Terms

Thank you for viewing the detailed overview of Solventum's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Solventum (Solventum) Business Description

Comparable Companies
Traded in Other Exchanges
Address
3M Center, St. Paul, MN, USA, 55144
Solventum is an independent healthcare?company with a primary focus on solving big healthcare challenges. Its diverse product portfolio spans across the healthcare industry from medical solutions and oral care to health information systems and separation and purification sciences.

Solventum (Solventum) Headlines

From GuruFocus